Alkermes PLC

8AK

Company Profile

  • Business description

    Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

  • Contact

    1 Burlington Road
    Connaught House
    DublinD04 C5Y6
    IRL

    T: +353 17728000

    https://www.alkermes.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    1,800

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,148.9093.601.16%
CAC 408,078.1093.37-1.14%
DAX 4022,899.07388.99-1.67%
Dow JONES (US)41,767.38197.25-0.47%
FTSE 1008,689.3717.29-0.20%
HKSE24,219.95551.19-2.23%
NASDAQ17,672.2178.58-0.44%
Nikkei 22537,751.8893.54-0.25%
NZX 50 Index12,054.728.790.07%
S&P 5005,650.8824.41-0.43%
S&P/ASX 2007,918.9090.601.16%
SSE Composite Index3,408.9517.48-0.51%

Market Movers